Safety and efficacy of extended release ketamine tablets in patients with treatment-resistant depression and anxiety: open label pilot study – Paul Glue, Natalie J. Medlicott, Shona Neehoff, Peter Surman, Fred Lam, Noelyn Hung, Cheung-tak Hung, 2020
— Read on journals.sagepub.com/doi/full/10.1177/2045125320922474
A very promising approach with the potential to safely and economically treat a wide range of patients.
LikeLiked by 1 person